ClinicalTrials.Veeva

Menu

Construction and Application of Precise Diagnosis and Treatment System for Thyroid-associated Ophthalmopathy

Zhejiang University logo

Zhejiang University

Status

Enrolling

Conditions

Thyroid Associated Ophthalmopathy

Treatments

Other: Imaging and ocular examinations

Study type

Observational

Funder types

Other

Identifiers

NCT07124572
2022-0592

Details and patient eligibility

About

This study aims to develop the deep learning-based system that integrates multimodal information to automatically diagnose, stage, and grade thyroid-associated ophthalmopathy (TAO), assist in treatment decision-making, and predict patient prognosis, thereby providing novel tools to support clinical management.

Enrollment

500 estimated patients

Sex

All

Ages

7 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • normal participants without eyelid disorders (control group)
  • patients with thyroid-associated ophthalmopathy (TAO group)
  • cooperative participants

Exclusion criteria

  • participants with pupil or cornea disorders
  • participants with history of eye injury

Trial design

500 participants in 2 patient groups

Participants without Thyroid-associated ophthalmopathy
Description:
Participants without thyroid-associated ophthalmopathy based on Bartley criteria.
Treatment:
Other: Imaging and ocular examinations
Patients with Thyroid-associated ophthalmopathy
Description:
Patients diagnosed as thyroid-associated ophthalmopathy based on Bartley criteria.
Treatment:
Other: Imaging and ocular examinations

Trial contacts and locations

1

Loading...

Central trial contact

Juan Ye

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems